4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus

from The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest · host The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest

Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus. For more information: Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association Anticoagulation Forum Rapid Resources LV Thrombus 2025 ACC/AHA Guidelines ACC 2025: Rivaroxaban Comparable to Warfarin in Left Ventricular Blood Clots

Episode metadata supplied by the publisher feed · Published Apr 22, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus

0:00 39:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest?

This episode is 39 minutes long.

When was this The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest episode published?

This episode was published on April 22, 2025.

Can I download this The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!